N-methyl-D-aspartate antagonists limit aminoglycoside antibiotic-induced hearing loss.
about
Dissociation of antibacterial activity and aminoglycoside ototoxicity in the 4-monosubstituted 2-deoxystreptamine apramycinMechanisms of aminoglycoside ototoxicity and targets of hair cell protection.N-acetyl-cysteine prevents age-related hearing loss and the progressive loss of inner hair cells in γ-glutamyl transferase 1 deficient mice.Free radicals and hearing. Cause, consequence, and criteriaExtracellular divalent cations modulate aminoglycoside-induced hair cell death in the zebrafish lateral lineExtracellular gentamicin reduces the activity of connexin hemichannels and interferes with purinergic Ca(2+) signaling in HeLa cells.A randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of neramexane in patients with moderate to severe subjective tinnitusGenetic analysis of interactions with eukaryotic rRNA identify the mitoribosome as target in aminoglycoside ototoxicity.Complementary roles of neurotrophin 3 and a N-methyl-D-aspartate antagonist in the protection of noise and aminoglycoside-induced ototoxicityCationic polyamines inhibit anthrax lethal factor proteaseGenetic factors in aminoglycoside toxicity.A radical demise. Toxins and trauma share common pathways in hair cell death.Effect of intratympanic dimethyl sulphoxide (DMSO) in an in vivo model of cisplatin-related ototoxicity.An update on otolaryngology in critical care.Protection of auditory receptors and neurons: evidence for interactive damage.Otoacoustic emission screen results in critically ill neonates who received gentamicin in the first week of life.The potential of targeting NMDA receptors outside the CNS.Cochlear synaptopathy in acquired sensorineural hearing loss: Manifestations and mechanisms.Glial cell line-derived neurotrophic factor. Potential for otoprotection.Cytotoxic effects of dimethyl sulphoxide (DMSO) on cochlear organotypic cultures.Steroids in aminoglycoside-containing ear drops: do they reduce cochlear toxicity?Sudden irreversible sensory-neural hearing loss in a patient with diabetes receiving amikacin as an antibiotic-heparin lock.Neuroprotection of vestibular sensory cells from gentamicin ototoxicity obtained using nitric oxide synthase inhibitors, reactive oxygen species scavengers, brain-derived neurotrophic factors and calpain inhibitors.Memantine's action against aminoglycoside-induced ototoxicity.Isosorbide delays gentamicin-induced vestibular sensory cell death.N-acetylcysteine use for amelioration of aminoglycoside-induced ototoxicity in dialysis patients.Brimonidine Protects Auditory Hair Cells from in vitro-Induced Toxicity of Gentamicin.Effects of Memantine on Aminoglycoside-Induced Apoptosis of Spiral Ganglion Cells in Guinea Pigs.Identification of ion-channel modulators that protect against aminoglycoside-induced hair cell death.Hearing loss and tinnitus--are funders and industry listening?Characteristics of ototoxicity of aminoglycosides "locked" to prevent hemodialysis catheter-related infections.Aminoglycoside excitement silences hearing.
P2860
Q27681169-7846A50E-98B4-4E55-9EE0-8A6F34B45365Q28393038-4359AFBD-E8A7-4A80-9A61-93ADF1869396Q28397956-84FEB4EC-02D3-4185-B63C-19D1A1F15E03Q28645793-BE2D19C0-F5FD-415D-AF76-D0AAC0D643FBQ30368370-9D8E6882-7055-4448-B50A-75E6D99C8982Q30430702-8BD8D94C-F0EA-4CC2-85B1-76CA085C35C3Q30477205-C2EB474F-27BA-4FB1-A3BA-BDAC78DC6777Q30488706-4B32354F-D711-4F66-9E7F-F9366ACAF558Q30504118-C0D9F70A-54C5-4198-87C7-83A841028DDEQ33246181-B923B51B-4781-4806-B62E-B9673111E7E4Q33936881-560F81E4-94E4-4E83-AC79-7514F347E866Q33936904-17A60C84-C720-44D1-BF02-5D273CE876E3Q35115020-D6FA07E1-CB87-42D5-AA62-EB0E99C1BD50Q35746986-61B4DB36-5202-4363-A152-23F31D11DBADQ36217123-EC5EE908-5211-43CC-A266-30B566C362A9Q37933379-50CD75A8-BF53-4BA8-8EDB-50923F6C71B3Q38286249-3261AB08-B19B-43D3-8E06-D12DD4887005Q39087848-D3681030-5FCB-4F10-A744-D86EA8D3A350Q40875441-693ED729-FC62-4FFE-AD38-BB7776D1631DQ42129681-89EFBD89-5C73-4021-AC78-0597C0FA77E4Q43798841-031FD2CE-FE3A-4F96-9238-F38CDBD73B5AQ43856628-E8120972-CDB0-4EAE-A61E-8F7548BC7F77Q44354761-FEA25D54-9BF8-4B7C-B609-8D8DC9B34092Q44607744-2587BFB4-7144-48A8-9374-2634E06E2F6EQ46461340-038B8BF2-D245-4EB8-9D39-4C456E9DAB16Q47608948-04EDE313-212A-4DAF-B83A-F0D6648E45B8Q47827626-9AFAEC43-5F23-4D82-AE9A-D0A5928C4C35Q47843182-F4259194-BEF7-42C4-B102-4EDE1307DE45Q49190945-131CBEDF-8193-4BB8-836C-E597C3226A3DQ50356330-0DFB3120-DB34-4ADB-B353-64B3170C08D7Q50467680-B969B197-74D7-45D1-8CF0-C63683818916Q50512552-293BB128-F697-452F-92DA-0E1860F9120F
P2860
N-methyl-D-aspartate antagonists limit aminoglycoside antibiotic-induced hearing loss.
description
1996 nî lūn-bûn
@nan
1996 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
N-methyl-D-aspartate antagonists limit aminoglycoside antibiotic-induced hearing loss.
@ast
N-methyl-D-aspartate antagonists limit aminoglycoside antibiotic-induced hearing loss.
@en
N-methyl-D-aspartate antagonists limit aminoglycoside antibiotic-induced hearing loss.
@nl
type
label
N-methyl-D-aspartate antagonists limit aminoglycoside antibiotic-induced hearing loss.
@ast
N-methyl-D-aspartate antagonists limit aminoglycoside antibiotic-induced hearing loss.
@en
N-methyl-D-aspartate antagonists limit aminoglycoside antibiotic-induced hearing loss.
@nl
prefLabel
N-methyl-D-aspartate antagonists limit aminoglycoside antibiotic-induced hearing loss.
@ast
N-methyl-D-aspartate antagonists limit aminoglycoside antibiotic-induced hearing loss.
@en
N-methyl-D-aspartate antagonists limit aminoglycoside antibiotic-induced hearing loss.
@nl
P2093
P2860
P356
P1433
P1476
N-methyl-D-aspartate antagonists limit aminoglycoside antibiotic-induced hearing loss.
@en
P2093
P2860
P2888
P304
P356
10.1038/NM1296-1338
P407
P577
1996-12-01T00:00:00Z